Funding for this research was provided by:
National Institute of General Medical Sciences (1R01GM101197-01A1, 1R34GM102696-01)
Received: 21 July 2017
Accepted: 9 August 2017
First Online: 29 August 2017
Ethics approval and consent to participate
: The University of Pittsburgh Institutional Review Board approved the ProACT trial.
: Not applicable.
: David T. Huang receives grant funding from ThermoFisher for a study examining the microbiome in lower respiratory tract infection.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.